Safety of testosterone use in women

Maturitas

Volumn 63, Issue 1, 2009, Pages 63-66

  Shufelt, Chrisandra L ^a   Braunstein, Glenn D ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Androgens; Breast cancer; Cardiovascular system; Endometrial cancer; Safety; Testosterone

Indexed keywords

ESTROGEN; HIGH DENSITY LIPOPROTEIN; NANDROLONE DECANOATE; PLACEBO; TESTOSTERONE;

ACNE; ALOPECIA; BEHAVIOR CHANGE; BLOOD PRESSURE; BLOOD VESSEL REACTIVITY; BLOOD VISCOSITY; BREAST CANCER; CANCER RISK; CARDIOVASCULAR RISK; CELL PROLIFERATION; DRUG SAFETY; ENDOMETRIUM HYPERPLASIA; EPITHELIUM CELL; HIRSUTISM; HORMONE SUBSTITUTION; HUMAN; HYPERCOAGULABILITY; LIVER TOXICITY; NONHUMAN; OVARY POLYCYSTIC DISEASE; POLYCYTHEMIA; POSTMENOPAUSE; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; VIRILIZATION;

BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; LIBIDO; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TESTOSTERONE;

EID: 67349179647     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.maturitas.2009.01.012     Document Type: Review

References (46)

1. Basaria S., and Dobs A.S. Safety and adverse effects of androgens: how to counsel patients. Mayo Clin Proc 79 (2004) S25-32
2. Schover L.R. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?. Fertil Steril (2007)
3. Gelfand M.M., and Wiita B. Androgen and estrogen-androgen hormone replacement therapy: a review of the safety literature, 1941 to 1996. Clin Ther 19 (1997) 383-404 [Discussion 367-8]
4. Davis S.R., Moreau M., Kroll R., et al. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 359 (2008) 2005-2017
5. Braunstein G.D. Safety of testosterone treatment in postmenopausal women. Fertil Steril 88 (2007) 1-17
6. Lobo R.A., Rosen R.C., Yang H.M., Block B., and Van Der Hoop R.G. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 79 (2003) 1341-1352
7. Barrett-Connor E., Young R., Notelovitz M., et al. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles. J Reprod Med 44 (1999) 1012-1020
8. Braunstein G.D., Sundwall D.A., Katz M., et al. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial. Arch Intern Med 165 (2005) 1582-1589
9. Buster J.E., Kingsberg S.A., Aguirre O., et al. Testosterone patch for low sexual desire in surgically menopausal women: a randomized trial. Obstet Gynecol 105 (2005) 944-952
10. Shifren J.L., Braunstein G.D., Simon J.A., et al. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343 (2000) 682-688
11. Vecerina-Volic S., Romic-Stojkovic R., Krajina Z., and Gamulin S. Androgen receptors in normal and neoplastic laryngeal tissue. Arch Otolaryngol Head Neck Surg 113 (1987) 411-413
12. Meyer III W.J.B.W., Cohen-Kettenis P., Coleman E., et al. The Harry Benjamin international gender dysphoria association's the standards of care for gender identity disorders, 6th version. Int J Transgender 5 (2001) 1-22
13. Gerritsma E.J., Brocaar M.P., Hakkesteegt M.M., and Birkenhager J.C. Virilization of the voice in post-menopausal women due to the anabolic steroid nandrolone decanoate (Decadurabolin). The effects of medication for one year. Clin Otolaryngol Allied Sci 19 (1994) 79-84
14. Bryant G.A., and Haselton M.G. Vocal cues of ovulation in human females. Biol Lett 5 1 (2009) 12-15
15. Sinha-Hikim I., Arver S., Beall G., et al. The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab 83 (1998) 1312-1318
16. Trenton A.J., and Currier G.W. Behavioural manifestations of anabolic steroid use. CNS Drugs 19 (2005) 571-595
17. Sherwin B.B., and Gelfand M.M. Sex steroids and affect in the surgical menopause: a double-blind, cross-over study. Psychoneuroendocrinology 10 (1985) 325-335
18. Dimitrakakis C., Zhou J., and Bondy C.A. Androgens and mammary growth and neoplasia. Fertil Steril 77 Suppl 4 (2002) S26-S33
19. Somboonporn W., and Davis S.R. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25 (2004) 374-388
20. Zhou J., Ng S., Adesanya-Famuiya O., Anderson K., and Bondy C.A. Testosterone inhibits estrogen-induced mammary epithelial proliferation and suppresses estrogen receptor expression. FASEB J 14 (2000) 1725-1730
21. Gammon M.D., and Thompson W.D. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 134 (1991) 818-824
22. Anderson K.E., Sellers T.A., Chen P.L., Rich S.S., Hong C.P., and Folsom A.R. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in a large prospective study of women in Iowa. Cancer 79 (1997) 494-499
23. Beattie M.S., Costantino J.P., Cummings S.R., et al. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP breast cancer prevention trial (P-1). J Natl Cancer Inst 98 (2006) 110-115
24. Berrino F., Muti P., Micheli A., et al. Serum sex hormone levels after menopause and subsequent breast cancer. J Natl Cancer Inst 88 (1996) 291-296
25. Hankinson S.E., Willett W.C., Manson J.E., et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 90 (1998) 1292-1299
26. Missmer S.A., Eliassen A.H., Barbieri R.L., and Hankinson S.E. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women. J Natl Cancer Inst 96 (2004) 1856-1865
27. Zeleniuch-Jacquotte A., Bruning P.F., Bonfrer J.M., et al. Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. Am J Epidemiol 145 (1997) 1030-1038
28. Zeleniuch-Jacquotte A., Shore R.E., Koenig K.L., et al. Postmenopausal levels of oestrogen, androgen, and SHBG and breast cancer: long-term results of a prospective study. Br J Cancer 90 (2004) 153-159
29. Hofling M., Hirschberg A.L., Skoog L., Tani E., Hagerstrom T., and von Schoultz B. Testosterone inhibits estrogen/progestogen-induced breast cell proliferation in postmenopausal women. Menopause 14 (2007) 183-190
30. von Schoultz B. Androgens and the breast. Maturitas 57 (2007) 47-49
31. Burgess H.E., and Shousha S. An immunohistochemical study of the long-term effects of androgen administration on female-to-male transsexual breast: a comparison with normal female breast and male breast showing gynaecomastia. J Pathol 170 (1993) 37-43
32. Gooren L.J., Giltay E.J., and Bunck M.C. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab 93 (2008) 19-25
33. Utian W.H., Archer D.F., Bachmann G.A., et al. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of the North American Menopause Society. Menopause 15 (2008) 584-602
34. Bulun S.E., Mahendroo M.S., and Simpson E.R. Polymerase chain reaction amplification fails to detect aromatase cytochrome P450 transcripts in normal human endometrium or decidua. J Clin Endocrinol Metab 76 (1993) 1458-1463
35. Tuckerman E.M., Okon M.A., Li T., and Laird S.M. Do androgens have a direct effect on endometrial function? An in vitro study. Fertil Steril 74 (2000) 771-779
36. Boman K., Strang P., Backstrom T., and Stendahl U. The influence of progesterone and androgens on the growth of endometrial carcinoma. Cancer 71 (1993) 3565-3569
37. Barrett-Connor E., and Goodman-Gruen D. Prospective study of endogenous sex hormones and fatal cardiovascular disease in postmenopausal women. BMJ 311 (1995) 1193-1196
38. Wu F.C., and von Eckardstein A. Androgens and coronary artery disease. Endocr Rev 24 (2003) 183-217
39. Zang H., Carlstrom K., Arner P., and Hirschberg A.L. Effects of treatment with testosterone alone or in combination with estrogen on insulin sensitivity in postmenopausal women. Fertil Steril 86 (2006) 136-144
40. Wagner J.D., Zhang L., Williams J.K., et al. Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys. Arterioscler Thromb Vasc Biol 16 (1996) 1473-1480
41. Cameron D.R., and Braunstein G.D. Androgen replacement therapy in women. Fertil Steril 82 (2004) 273-289
42. Barlow D.H., Abdalla H.I., Roberts A.D., Al Azzawi F., Leggate I., and Hart D.M. Long-term hormone implant therapy-hormonal and clinical effects. Obstet Gynecol 67 (1986) 321-325
43. Worboys S., Kotsopoulos D., Teede H., McGrath B., and Davis S.R. Evidence that parenteral testosterone therapy may improve endothelium-dependent and -independent vasodilation in postmenopausal women already receiving estrogen. J Clin Endocrinol Metab 86 (2001) 158-161
44. Advisory Committee for Reproductive and Urologic Drug Products; 2004. http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4082B1_02_B-FDA-Intrinsa-Medical-Review.htm.
45. Basaria S., Nguyen T., Rosenson R.S., and Dobs A.S. Effect of methyl testosterone administration on plasma viscosity in postmenopausal women. Clin Endocrinol (Oxf) 57 (2002) 209-214
46. Buckler H.M., McElhone K., Durrington P.N., Mackness M.I., Ludlam C.A., and Wu F.C. The effects of low-dose testosterone treatment on lipid metabolism, clotting factors and ultrasonographic ovarian morphology in women. Clin Endocrinol (Oxf) 49 (1998) 173-178